 |
PDBsum entry 2xmy
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
Discovery and characterisation of 2-anilino-4-(thiazol-5-yl) pyrimidine transcriptional cdk inhibitors as anticancer agents
|
|
Structure:
|
 |
Cell division protein kinase 2. Chain: a. Synonym: p33 protein kinase. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Expression_system_cell_line: sf9.
|
|
Resolution:
|
 |
|
1.90Å
|
R-factor:
|
0.192
|
R-free:
|
0.271
|
|
|
Authors:
|
 |
S.Wang,G.Griffiths,C.A.Midgley,A.L.Barnett,M.Cooper,J.Grabarek, L.Ingram,W.Jackson,G.Kontopidis,S.J.Mcclue,C.Mcinnes,J.Mclachlan, C.Meades,M.Mezna,I.Stuart,M.P.Thomas,D.I.Zheleva,D.P.Lane, R.C.Jackson,D.M.Glover,D.G.Blake,P.M.Fischer
|
|
Key ref:
|
 |
S.Wang
et al.
(2010).
Discovery and characterization of 2-anilino-4- (thiazol-5-yl)pyrimidine transcriptional CDK inhibitors as anticancer agents.
Chem Biol,
17,
1111-1121.
PubMed id:
|
 |
|
Date:
|
 |
|
29-Jul-10
|
Release date:
|
10-Nov-10
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P24941
(CDK2_HUMAN) -
Cyclin-dependent kinase 2 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
298 a.a.
295 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.11.22
- cyclin-dependent kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
Chem Biol
17:1111-1121
(2010)
|
|
PubMed id:
|
|
|
|
|
| |
|
Discovery and characterization of 2-anilino-4- (thiazol-5-yl)pyrimidine transcriptional CDK inhibitors as anticancer agents.
|
|
S.Wang,
G.Griffiths,
C.A.Midgley,
A.L.Barnett,
M.Cooper,
J.Grabarek,
L.Ingram,
W.Jackson,
G.Kontopidis,
S.J.McClue,
C.McInnes,
J.McLachlan,
C.Meades,
M.Mezna,
I.Stuart,
M.P.Thomas,
D.I.Zheleva,
D.P.Lane,
R.C.Jackson,
D.M.Glover,
D.G.Blake,
P.M.Fischer.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |